Abstracts

Search by keyword or author name.

Showing 850 abstracts.

John ( Jack ) Moye, Jr., M.D., E. Richard Stiehm, M.D., James Bethel, Ph.D., Helene M.A. Paxton, M.S., M.T., Hildie Suter, B.S., Susan Plaeger, Ph.D., Howard Max Rosenblatt, M.D., Alan Landay, Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Bonnie J. Mathieson, Ph.D., Jonathan Kagan, Ph.D. 3-Color Flow Cytometric Markers of Lymphocyte Activation and Memory in Perinatal HIV Transmission and Infant Infection.
Courtney V. Fletcher, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Terence Fenton, Ed.D., William D. Fiske, Ph.D., David Kornhauser, M.D., James McNamara, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Stuart E. Starr, M.D. Efavirenz (EFV) and Nelfinavir (NFV) Pharmacokinetics (PK) In HIV-Infected Children Participating In An Area Under the Curve (AUC) Controlled Trial.
Jane C. Lindsey, Sc.D., Michael Hughes, Ph.D., John ( Jack ) Moye, Jr., M.D., Ross E. McKinney, Jr., M.D., Mary K. Cowles, Ph.D. A Meta-analysis Of Treatment Mediated Changes In HIV-1 RNA and CD4 Counts As Predictors Of Clinical Endpoints In HIV-Infected Children.
David E. Shapiro, Ph.D., Ruth E. Tuomala, M.D., Renee Samelson, M.D., Sandra K. Burchett, M.D., M.S., Gregory Ciupak, B.A., James McNamara, M.D., Henry Pollack, M.D., Jennifer S. Read, M.D., M.P.H., M.S., DTM&H. Antepartum Antiretroviral Therapy and Pregnancy Outcomes In 462 HIV-Infected Women In 1998-1999 (PACTG 367).
Mark W. Kline, M.D., Courtney V. Fletcher, Pharm.D., Jane C. Lindsey, Sc.D., Terence Fenton, Ed.D. A Randomized Trial of Two Saquinavir (SQV-SGC)-Containing Combination Treatment Regimes in HIV-Infected Children.
Stuart E. Starr, M.D., Courtney V. Fletcher, Pharm.D., Stephen A. Spector, M.D., Richard Brundage, Pharm.D., Ph.D., Florence H. Yong, M.S., Douglas J. Manion, M.D., F.R.C.P., James McNamara, M.D., Lynne M. Mofenson, M.D., F.A.A.P. Safety and Antiviral Effect of Combination Therapy with Efavirenz, Nelfinavir, and Nucleoside Reverse Transcriptase Inhibitors in Human Immunodeficiency Virus Type 1-Infected Children.
Sandra K. Burchett, M.D., M.S., Vincent J. Carey, Ph.D., Florence H. Yong, M.S., John L. Sullivan, M.D., Steven Sulzbacher, Ph.D., Lucy Civitello, M.D., Mary Culnane, C.R.N.P., M.S., Lynne M. Mofenson, M.D., F.A.A.P., Suzanne Siminski, M.S., M.B.A., Patrick Robinson, M.D., Katherine Luzuriaga, M.D. Virologic Activity Of Didanosine (DDL), Zidovudine (ZDV) and Nevirapine (NVP) Combinations In Pediatric Subjects With Advanced Disease.
Arlene D. Bardeguez, M.D., M.P.H., F.A.C.O.G., Lynne M. Mofenson, M.D., F.A.A.P., Mary Glenn Fowler, M.D., M.P.H., Catherine Spino, Sc.D., David E. Shapiro, Ph.D., Rhoda S. Sperling, M.D., Pamela J. Boyer, M.D. Lack of Clinical or Immunological Disease Progression with Transient Use of Zidovudine (ZDV) to Reduce Perinatal HIV-1 Transmission in PACTG 076.
Sharon Appelbaum Nachman, M.D., Jane C. Lindsey, Sc.D., Wayne M. Dankner, M.D., Andrew A. Wiznia, M.D., Sophia S. Lee, M.S., Ram Yogev, M.D., Kenneth McIntosh, M.D., Stephen Ira Pelton, M.D. Lack Of Improvement In Growth In HIV-Infected Children On HAART.
Katherine Luzuriaga, M.D., Margaret McManus, B.S., Shane Mayack, Mark Sharkey, John L. Sullivan, M.D. Evidence For Cessation Of Viral Replication and Absence Of Virus-Specific Immunity.